ESC 365 - Randomised double-blind placebo-controlled study of the effects of candesartan versus amlodipine treatment on capillary rarefaction in patients with essential hypertension (CAMIRA Trial)

ESC Premium Access

Randomised double-blind placebo-controlled study of the effects of candesartan versus amlodipine treatment on capillary rarefaction in patients with essential hypertension (CAMIRA Trial)

Session: Poster session 2 - Treatment of hypertension

Topic: Treatment of hypertension

Speaker: Doctor T. Antonios (London, GB)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Tarek Francis Antonios

St George's Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

10 more presentations in this session

Ten-year target systolic blood pressure less than 120 mmHg for more than 65 aged hypertension patients with chronic renal disease.

Inhibition of left ventricular hypertrophy and normalization of cardiac contractile response in relation with oxidative stress in experimental hypertension

Speaker: Professor J. Milei (Buenos Aires, AR)

Efficacy of fixed-dose combination perindopril arginine/amlodipine switched from ineffective renin-angiotensin system inhibitor based free combinations: POTENTIAL study subanalysis.

Speaker: Professor M. Glezer (Moscow, RU)

Pleiotropic effects of antihypertensives in genetically hypertensive rats

Speaker: Professor J. Milei (Buenos Aires, AR)

Endothelium as a target organ of therapeutic effect in women with arterial hypertension with estrogen deficiency

Speaker: Doctor R. Stryuk (Moscow, RU)

Access the full session

Poster session 2 - Treatment of hypertension

Speakers: Doctor T. Antonios, Professor J. Milei, Professor M. Glezer, Professor J. Milei, Doctor R. Stryuk

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources